Lipoprotein composition in NIDDM: Effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins

Diabetologia

Volumn 39, Issue 6, 1996, Pages 667-676

  Dimitriadis, E ^a   Griffin, M ^b   Collins, P ^c   Johnson, A ^c   Owens, D ^a   Tomkin, G H ^a,c,d  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d NONE   (Ireland)

Author keywords

Conjugated dienes; Fatty acids; Lipid peroxidation; Low density lipoprotein; Low density lipoprotein oxidation; Non insulin dependent diabetes mellitus

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID PEROXIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OLEIC ACID;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; FEMALE; HUMAN; LIPID METABOLISM; LIPOPROTEIN OXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; OXIDATION; PRIORITY JOURNAL;

EID: 0029951614     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00418538     Document Type: Article

References (39)

1. Bowie A, Owens D, Collins R Johnson A, Tomkin GH (1993) Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? Atherosclerosis 102: 63-67
2. Dimitriadis E, Griffin M, Owens D, Johnson A, Collins P, Tomkin GH (1995) Oxidation of low density lipoprotein in non-insulin-dependent diabetes: its relationship to fatty acid composition. Diabetologia 38: 1300-1306
3. Griffin M, Dimitriadis E, Lenehan K et al. Non-insulin-dependent diabetes mellitus - dietary monounsaturated fatty acids, low density lipoprotein composition and function. Quart J Med (in press)
4. Reaven P, Parthasarathy S, Grass BJ et al. (1991) Feasibility of using an oleate-rich diet to reduce lipoprotein oxidation in humans. Am J Clin Nutr 54: 701-706
5. Reaven P, Parthasarathy S, Grass BJ, Miller E, Steinberg D (1993) Effects of oleate-rich and linoleate-rich diets on susceptibility of low density lipoproteins to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 9: 668-676
6. Parfitt FJ, Desomeaux K, Bolton CH, Hartog MS (1994) Effects of high monounsaturated and polyunsaturated fat diets on plasma lipoproteins and lipid peroxidation in type 2 diabetes mellitus. Diabet Med 11: 85-91
7. Gordon DJ, Rifkind BM (1989) High density lipoproteins - the clinical implications of recent studies. N Engl J Med 321: 1311-1318
8. Parthasarathy S, Barnett J, Fong LG (1990) High density lipoprotein inhibits the oxidative modification of low density lipoprotein. Biochim Biophys Acta 1044: 275-283
9. Klimov AN, Gurevich VS, Nikiforova AA et al. (1993) Antioxidant activity of high density lipoproteins in vivo. Atherosclerosis 103: 13-18
10. Ohta T, Takata S, Morino Y, Matesuda I (1989) Protective effect of lipoproteins containing apo A-1 on lipoperoxides in low density lipoprotein. FEBS Letts 257: 435-438
11. Kunitake ST, Jarvis MR, Hamilton RL, Kane JP (1992) Binding of transition metals by apolipoprotein A1-containing lipoproteins: inhibition of oxidation of low density lipoprotein. Proc Natl Acad Sci USA 89: 6993-6997
12. Mackness MJ, Abbott C, Arrol S, Durrington PN (1993) The role of high density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low density lipoprotein oxidation. Biochem J 294: 829-834
13. Mackness MJ, Arrol S, Abbott C, Durrington PN (1993) Protection of low density lipoprotein against oxidative modification of high density lipoprotein associated paraoxinase. Atherosclerosis 104: 129-135
14. Mackness MJ, Harty D, Bhatnagar D et al. (1991) Serum paraoxinase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 86: 103-109
15. Harats D, Ben-Naim M, Dabach Y, Hollander G, Stein O, Stein Y (1989) Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 79: 245-252
16. Markwell MAK, Mass SM, Bieber LL, Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206-210
17. Havel RA, Eder HM, Brydon JH (1985) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353
18. Folch J, Lees M, Sloane SGH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 479-509
19. Sattler W, Puhl W, Kostner GM, Esterbauer H (1991) Determination of fatty acids in the main lipoprotein classes by capillary gas chromatography: BF3/Methanol transesterification of lyophilised samples instead of Folch extraction gives higher yields. Anal Biochem 198: 184-190
20. Esterbauer H, Striegel G, Puhl H, Kothender M (1989) Continuous monitoring of in vitro oxidation of human low-density lipoproteins. Free Radical Res Commun 6: 67-75
21. Croft KD, Williams P, Dimmitt S, Abu-Amsha R, Beilin LJ (1994) Oxidation of low-density lipoproteins: effect of antioxidant content, fatty acid composition and intrinsic phospholipase activity on susceptibility to metal ion-induced oxidation. Biochim Biophys Acta 1254: 250-256
22. El-Saadani M, Esterbauer H, El-Saved M, Goher M, Nassar AY, Jurgens G (1989) A spectrophotometric assay for the lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 30: 627-630
23. Kaplan LA, Miller JA, Stein EA (1987) Simultaneous measurement of serum retinol, tocopherols, carotenes and carotenoids by high performance liquid chromatography. J Clin Lab Anal 1: 147-152
24. Jack CM, Sheridan B, Kennedy L, Stout RW (1988) Non-enzymatic glycosylation of low density lipoproteins. Results of an affinity chromatography method. Diabetologia 31: 126-127
25. Nikkari T (1986) Serum fatty acids and coronary heart disease in Finnish populations. Prog Lipid Res 25: 437-450
26. Collier A, Wilson R, Bradley H, Thompson JA, Small MS (1990) Free radical activity in type 2 diabetes. Diabet Med 7: 27-30
27. Esterbauer H, Gebicki J, Puhl H, Jurgens G (1992) The role of lipid peroxidation and antioxidants in the oxidative modification of LDL. Free Radical Biol Med 13(4): 341-350
28. Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum JL, Steinberg D (1990) Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA 87: 3894-3898
29. Varma SP, Philippot JR, Bonnet B et al. (1990) Structural abnormalities in LDL from diabetic patients as revealed by Raman spectroscopy. Diabetes 39: 1451-1456
30. Sato Y, Hotta N, Sakamoto N et al. (1979) Lipid peroxide level in plasma of diabetic patients. Biochim Med 21: 104-107
31. Nishigaki I, Hagihara M, Tsunekawa H, Maseki M, Yagi K (1991) Lipid peroxide levels of serum lipoproteins of diabetic patients. Biochem Med 25: 373-378
32. Nourooz-Zadeh J, Tajaddani-Saramadi J, McCarthy S, Betteridge DJ. Wolff SP (1995) Elevated levels of authentic hydroperoxides in NIDDM. Diabetes 44: 1054-1058
33. Frei B, Gaziano JMS (1993) Content of antioxidants, preformed lipid peroxides and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and independent oxidation. J Lipid Res 34: 2135-2145
34. Mullarkey CJ, Edelstein D, Brownlee M (1990) Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochim Biophys Res Commun 173: 932-939
35. Wolff SP (1993) Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 49: 642-652
36. Hunt J, Smith CCT, Wolff SP (1990) Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39: 1420-1424
37. Niskanen LK, Salonen JT, Myyssonen K, Uusitupa MIJ (1995) Plasma lipid peroxidation and peroxidation; a connection through hyperinsulinaemia. Diabet Med 12: 802-808
38. Ruiz J, Blanche H, James RW et al. (1995) Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet 346: 869-872
39. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV (1993) The relation between insulin-sensitivity and fatty acid composition of skeletal muscle phospholipids. N Engl J Med 328: 238-244